financetom
HBT
financetom
/
Financials
/
HBT
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
HBT Financial, Inc.HBT
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

HBT Financial, Inc. operates as the bank holding company for Heartland Bank and Trust Company that provides business, commercial, and retail banking products and services to individuals, businesses, and municipal entities in Central and Northeastern Illinois, and Eastern Iowa.

The company's deposits accounts consist of noninterest-bearing demand deposits, interest-bearing transaction accounts, money market accounts, savings accounts, certificates of deposits, health savings accounts, and individual retirement accounts.

Its loan offering comprises owner and non-owner occupied commercial real estate; construction and land development and multi-family; commercial and industrial; agricultural and farmland; and one-to-four family residential loans, as well as municipal, consumer, and other loans.

The company also offers wealth management services, including financial planning to consumers, trusts, and estates; trustee and custodial; investment management; corporate retirement plan consulting and administration; and retail brokerage services.

In addition, it provides farmland management, and farmland sales and services; and treasury management services, as well as originates and sells residential mortgage loans.

Further, the company offers digital banking services, such as online and mobile banking, and digital payment services, as well as personal financial management tools.

The company was formerly known as Heartland Bancorp, Inc. and changed its name to HBT Financial, Inc. in September 2019.

HBT Financial, Inc. was founded in 1920 and is headquartered in Bloomington, Illinois.

Latest News >
Monroe Capital Supports Respida Capital’s Acquisition of ENTOUCH
Monroe Capital Supports Respida Capital’s Acquisition of ENTOUCH
Nov 10, 2025
CHICAGO--(BUSINESS WIRE)-- Monroe Capital LLC (“Monroe”) announced it led the growth capital investment to support the acquisition of ENTOUCH by Respida Capital. Founded in Dallas, Texas in 2008, ENTOUCH provides energy management as a service and smart building technology. The company’s cloud-based software delivers sustainable solutions that reduce energy usage, drive profitably, and simplify facility management for multisite operators. “We...
Optimism Around US Government Shutdown End, China Inflation Views Lift Asian Stock Markets
Optimism Around US Government Shutdown End, China Inflation Views Lift Asian Stock Markets
Nov 10, 2025
05:38 AM EST, 11/10/2025 (MT Newswires) -- Asian stock markets rose Monday following media reports that the US government shutdown may be nearing an end, and after relatively positive inflation reports from Beijing. Hong Kong, Shanghai and Tokyo finished in the green, as did most other regional exchanges. The South Korean KOSPI rose 3% on the US outlook, and hopes...
Cargojet Renews Normal Course Issuer Bid for Voting Shares
Cargojet Renews Normal Course Issuer Bid for Voting Shares
Nov 10, 2025
05:55 AM EST, 11/10/2025 (MT Newswires) -- Cargojet ( CGJTF ) , which rose 2.5% on Friday, later that day said it has received approval from the Toronto Stock Exchange to renew its normal course issuer bid for common voting shares and variable voting shares. The NCIB is scheduled to run from Nov. 11, 2025, to Nov. 10, 2026. Purchases...
Merck's Phase 3 Trial of Enlicitide Decanoate in Heterozygous Familial Hypercholesterolemia Achieves Primary Endpoint
Merck's Phase 3 Trial of Enlicitide Decanoate in Heterozygous Familial Hypercholesterolemia Achieves Primary Endpoint
Nov 10, 2025
05:54 AM EST, 11/10/2025 (MT Newswires) -- Merck ( MRK ) said Sunday that a phase 3 study of its elicitide decanoate product candidate achieved its primary endpoint, demonstrating statistically significant reduction in low-density lipoprotein cholesterol, or LDL-C, in adult patients with heterozygous familial hypercholesterolemia. The company said enlicitide led to a clinically meaningful LDL-C reduction of 59.4% compared with...
Copyright 2023-2026 - www.financetom.com All Rights Reserved